secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0001193125-26-058063
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q4 EPS $0.40; Adj. EPS $0.50; guides 2026 EBITDA $280-300M
--------------------------------------------------------------------

- Net revenue $494M, down slightly YoY; same-unit revenue up 4.0%.
- Q4 GAAP net income $33.7M ($0.40/share) vs $30.5M ($0.36) prior year; Adjusted EPS $0.50.
- Full year 2025 Adjusted EBITDA $275.6M, up from $224M; Adjusted EPS $2.04 vs $1.51.
- Preliminary 2026 Adjusted EBITDA guidance $280-300M, above 2025's $275.6M.
- Cash from operations $114.6M in Q4; used $64M for share repurchases; total debt $597M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000119312526058063/0001193125-26-058063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000119312526058063/md-20260219.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-058063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer